Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *

Products » Items » Zalastin


Contraindicated
Foetotoxic in animals

Not recommended
Zalastin :
Type Medicine Non Marketed
Originator Allergodil Nasal Spray
Agent C. Catafago & Co
Distributor C. Catafago & Co
Laboratory EEP
Responsible Party European Egyptian Pharmaceutical Industries
Origin Egypt
Manufacturer European Egyptian Pharmaceutical Industries
Manufacturing Type G
Origin Egypt
ATC R01AC03

Your comment will appear shortly after approval

Zalastin :

Revision Date : 01/02/2011


Effect Frequency
Epistaxis (Nasal bleeding) Uncommon
Hypersensitivity reactions Very rare
Nasal oedema (Nasal mucosal swelling) Uncommon
Pruritus Very rare
Skin rash Very rare
Sneezing Uncommon
Taste bitter Common
Urticaria Very rare

Different Units By MoH Code

Revision Date : no date

Zalastin Zalastin Zalastin Zalastin Zalastin Zalastin

Zalastin  MoH 6946 :
Form Nasal spray, solution
Packaging Vial (Type III Glass)
Package Size 15ml
Strength 140µg/dose
NSSF ✘
Quarantine ✘
Reg. Number 218161/09
Submission date 01/01/2009
Registration Year 2013
Archived Date 02/03/2023
Barcode 6221076160274


Price Comparison

● Country: Egypt
● Package Size: 15ml
● Public Price: 23.496 EGP ( 42,880.20 LBP )
● Pack size unit used: 75
● Cost/Unit: 0,3133 EGP ( 0.00 LBP )
● Pricing Date: 20/11/2019
● Type: Medicine Authorised

    ◼ Lebanon
    ◼ Country of Origin
    ◼ Reference Countries
    ◼ Other Countries
Prices are provided in Dollar ($)
You have to register to view this info

You have to register to view this info

You have to register to view this info